Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 706 AL 720

Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease

Liu Y, Zhang Z, Zhu Z, Yang Y, Peng W, Chen Q, Mak S, Tism KW, Pi R.

Mini Rev Med Chem. 2025;25(2):163-175. doi: 10.2174/0113895575330648240819112435.

Basic approach on the protective effects of hesperidin and naringin in Alzheimer's disease

Kuşi M, Becer E, Vatansever HS.

Nutr Neurosci. 2025 May;28(5):550-562. doi: 10.1080/1028415X.2024.2397136. Epub 2024 Sep 3.

Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease

Tang S, Zhang Y, Botchway BOA, Wang X, Huang M, Liu X.

Mol Neurobiol. 2025 Mar;62(3):3493-3507. doi: 10.1007/s12035-024-04498-6. Epub 2024 Sep 20.

Harnessing the benefits of physical exercise-induced melatonin: a potential promising approach to combat Alzheimer's disease by targeting beta-amyloid (Aβ)

Bian R, Xiang L, Su Z.

Hormones (Athens). 2025 Mar;24(1):3-13. doi: 10.1007/s42000-024-00602-6. Epub 2024 Sep 23.

Molecular Therapeutics in Development to Treat Alzheimer's Disease

Tartaglia MC, Ingelsson M.

Mol Diagn Ther. 2025 Jan;29(1):9-24. doi: 10.1007/s40291-024-00738-6. Epub 2024 Sep 24.

Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions

Kumar BS, Dinesh BGH, Shajan SRO, Sadashivappa NM, Ammunje DN, Kunjiappan S, Theivendren P, Pavadai P.

Curr Pharm Des. 2025;31(17):1347-1369. doi: 10.2174/0113816128334916241006195142.

Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article

Alshiban A, Hasoglu T, Oster J.

Am J Geriatr Psychiatry. 2025 Feb;33(2):209-218. doi: 10.1016/j.jagp.2024.09.016. Epub 2024 Oct 3.

Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease

Kaur P, Khan H, Grewal AK, Dua K, Singh SK, Gupta G, Singh TG.

CNS Neurol Disord Drug Targets. 2025;24(3):196-207. doi: 10.2174/0118715273321002240919102841.

A Lipid-Raft Theory of Alzheimer's Disease

Rappoport A.

Annu Rev Biochem. 2025 Jun;94(1):387-416. doi: 10.1146/annurev-biochem-052024-115455. Epub 2024 Oct 30.

From defense to disease: IFITM3 in immunity and Alzheimer's disease

Kehs Z, Cross AC, Li YM.

Neurotherapeutics. 2025 Apr;22(3):e00482. doi: 10.1016/j.neurot.2024.e00482. Epub 2024 Nov 8.

The Amyloid Cascade Hypothesis: A Conclusion in Search of Support

Castellani RJ, Jamshidi P, Plascencia-Villa G, Perry G.

Am J Pathol. 2025 Nov;195(11):1988-1997. doi: 10.1016/j.ajpath.2024.10.014. Epub 2024 Nov 10.

Investigating interleukin-8 in Alzheimer's disease: A comprehensive review

Righi D, Manco C, Pardini M, Stufano A, Schino V, Pelagotti V, Massa F, Stefano N, Plantone D.

J Alzheimers Dis. 2025 Jan;103(1):38-55. doi: 10.1177/13872877241298973. Epub 2024 Nov 18.

The LDL Receptor-Related Protein 1: Mechanisms and roles in promoting Aβ efflux transporter in Alzheimer's disease

Li W, Chen C, Xu B, Chen J, Yang M, Gao L, Zhou J.

Biochem Pharmacol. 2025 Jan;231:116643. doi: 10.1016/j.bcp.2024.116643. Epub 2024 Nov 20.

The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer's disease

Salminen A.

J Mol Med (Berl). 2025 Jan;103(1):1-19. doi: 10.1007/s00109-024-02504-x. Epub 2024 Nov 27.

The role of kynurenine pathway metabolism mediated by exercise in the microbial-gut-brain axis in Alzheimer's disease

Wang Y, Wu W, Zeng F, Meng X, Peng M, Wang J, Chen Z, Liu W.

Exp Neurol. 2025 Feb;384:115070. doi: 10.1016/j.expneurol.2024.115070. Epub 2024 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias